A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:
Back to home » Top Stories » CROI 2009
CROI 2009 16th Conference on Retroviruses and Opportunistic Infections
Montréal, Canada
February 8-11, 2009

Half of Deaths in People With HIV No Longer From AIDS

February 23, 2009

By David Evans

Half of the deaths in people with HIV now are from causes other than AIDS, according to a study presented at the 16th Conference on Retroviruses and Opportunistic Infections (CROI) in Montreal. Non-AIDS-related cancers and cardiovascular disease are a growing cause of death particularly in older people with HIV.

Testifying to the success of antiretroviral (ARV) therapy, death rates have plummeted since the early 1990s. Yet as the rates of most AIDS-related conditions have declined well below 25 percent of what they once were, other diseases are emerging as substantial risk factors.

To determine the most important causes of mortality among people with HIV, John Gill, MSc, from the University of Calgary in Canada and his colleagues examined the circumstances surrounding the deaths of 1,597 people with HIV enrolled in one of 13 cohort studies in Europe and North America between 1996 and 2006. Those who died were compared with more than 36,000 other people with HIV in the cohorts who did not die during the study period.

Deaths were AIDS-related in 63 percent of those who died within their first year of taking combination ARV therapy. After the first year of treatment, the rate of deaths that were AIDS-related dropped to 43 percent. Twelve percent of the deaths were from non-AIDS-related cancers; 9 percent were from heart attacks, strokes or other forms of heart disease; 8 percent were from non-AIDS-related infections; and 7 percent were from liver disease.

When Gill’s team looked at the influence of CD4 counts on death, it found not-surprisingly that people with fewer than 100 CD4 cells before starting HIV treatment were four times more likely to die from AIDS-related causes than people with CD4 counts above 350. They also found, however, that people with pre-treatment CD4 counts below 100 were 61 percent more likely to die from heart problems, 96 percent more likely to die from respiratory diseases such as emphysema and nearly 11 times more likely to die from kidney failure. There was also a particularly strong association between older age and the likelihood of dying from a non-AIDS-related cancer or heart disease among all individuals.

People with a history of injection drug use were six times more likely to die from liver disease, five times more likely to die from lung diseases, nearly four times as likely to die from heart disease and nearly three times as likely to die from cancer as people with no history of injection drug use. They were also nearly four times as likely to die as a victim of violence.

Gill’s team recommends that further research and efforts must be explored to understand and treat these non-AIDS-related causes of death.

Scroll down to comment on this story.

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 1 (of 1 total)    

candie, jacksonville, 2009-03-15 12:01:53
But children are dying from the HIV meds meant to save their lives. The diseases listed are not AIDS related but someone needs to research them being HIV Meds related.

comments 1 - 1 (of 1 total)    

More from CROI 2009

HIV/AIDS Complications

March 4, 2009
HIV and Women
February 26, 2009
HIV and the Brain: What to Watch Out For
February 25, 2009
HIV and Cancer: Prevalence and Prevention
February 23, 2009
Half of Deaths in People With HIV No Longer From AIDS
February 20, 2009
Testosterone Therapy: Good for Women Too
Lymphoma: Death Rates Still High, but Cancer May Be Predicted
February 19, 2009
Quarter of U.S. Positive Women Not Receiving Annual Pap Smears
February 18, 2009
HDL and Small HDL Particles Predict Cardio Problems in HIV
Scientists Still Seeking Clues to Abacavir Heart Attack Mystery
February 17, 2009
Smoking Cessation: Hispanics, Nicotine Patch Users Do Best
Nerve Damage Is a Common Problem in People With HIV
February 11, 2009
PIs, Abacavir and Cardiovascular Disease: What’s the Risk?
D:A:D Study: Reduce Modifiable Risk Factors to Improve Survival
HIV Itself Is a Major Heart Disease Risk Factor
February 10, 2009
Age, Diabetes & a Bigger Waist Line Tied to Cognitive Problems in HIV
February 9, 2009
Diabetes Drug Avandia Helps Reverse Lipoatrophy

HIV Transmission and Prevention

February 27, 2009
Prevention Highlights, Part 1: PrEP
Prevention Highlights, Part 2: Treatment as Prevention
February 13, 2009
Microbicides Make a Comeback
February 9, 2009
HIV Treatment Greatly Reduces, But Doesn’t Eliminate Transmission

Starting and Switching Treatment

February 12, 2009
Isentress Shows Long-Term Benefits in Treatment-Experienced Patients
Antidepressants Improve Viral Load Response to Treatment Due to Better Adherence
February 10, 2009
Start HIV Treatment Early—But When?
February 9, 2009
Kaletra-to-Isentress Switch Helps Lipids, but With Viral Rebound Risk

Experimental HIV Drugs

February 20, 2009
Antiretroviral Highlights from CROI
February 10, 2009
IL-2 Fails in Two Large Studies
February 9, 2009
GS 9350 and SPI-452: Emerging Alternatives to Norvir Boosting


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.